Bradley J. Bolzon Ph.D., Director, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 32,469 shares at $33.09 ($1.1M) on 2020-10-14, disclosed to the SEC on 2020-10-15.
Open-market sale of $1.1M BDTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.39 | 1,369 | $46K | 4.2% |
| 2 | $33.39 | 10,370 | $346K | 32.0% |
| 3 | $33.39 | 10,370 | $346K | 32.0% |
| 4 | $33.09 | 642 | $21K | 2.0% |
| 5 | $33.09 | 4,859 | $161K | 14.9% |
| 6 | $33.09 | 4,859 |
| $161K |
| 14.9% |
| Total | $33.29 avg | 32,469 | $1.1M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |